Neurology/psychiatric

RSS

Anesta's Actiq denied FDA approval

Nov. 17, 1997

Anticonvulsants with reduced side effects from RCT

Nov. 17, 1997

Brain GABA-A receptor ligands prepared at Neurogen

Nov. 17, 1997

Aradigm tests inhalation form of morphine in volunteers

Nov. 14, 1997

nNOS inhibitor from Astra effective in animal models of stroke, ALS

Nov. 14, 1997

Roche in-licenses promising antiparkinsonian agent

Nov. 14, 1997

CCK/gastrin receptor ligands from James Black Foundation

Nov. 13, 1997

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

FDA review of Myotrophin continues after resubmission

Nov. 12, 1997

New neuroprotectants disclosed by Nippon Shinyaku

Nov. 12, 1997